{"disease":{"id":"dengue-hemorrhagic-fever","name":"dengue hemorrhagic fever"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02948933","title":"Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine","phase":"","overall_status":"COMPLETED","enrollment_count":30000,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT01373281","title":"Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":10275,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT07543458","title":"Therapeutics for Moderate and Severe Dengue","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":8800,"lead_sponsor_name":"Oxford University Clinical Research Unit, Vietnam","has_results":false},{"nct_id":"NCT02628444","title":"Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1050,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02992418","title":"Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":688,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02993757","title":"Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":528,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02979535","title":"Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":480,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT01488890","title":"Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":390,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT00788151","title":"Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT06642493","title":"Efficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue Patients","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Sheikh Hasina National Institute of Burn and Plastic Surgery","has_results":false},{"nct_id":"NCT06744777","title":"The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":284,"lead_sponsor_name":"Khyber Medical University Peshawar","has_results":false},{"nct_id":"NCT02623725","title":"Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":251,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT04048837","title":"Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"National University Hospital, Singapore","has_results":false},{"nct_id":"NCT07205848","title":"Evaluating Public Awareness and Preventive Actions for Dengue Fever in Sudan Amidst Ongoing Crises","phase":"","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"Research and Publication office","has_results":false},{"nct_id":"NCT02741128","title":"Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02824198","title":"Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT01943825","title":"Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03432442","title":"Pharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Mahidol University","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}